Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
9
9 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- FelzartamabPhase 38 trials
Biogen · Antibody-mediated Rejection, Microvascular Inflammation, Graves' Disease
- LitifilimabBIIB059Phase 35 trials
Biogen · Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus, Lupus Erythematosus, Systemic
- SalanersenBIIB115Phase 33 trials
Biogen · Muscular Atrophy, Spinal, Spinal Muscular Atrophy
- DNL151BIIB122Phase 22 trials
Denali Therapeutics Inc. · Parkinson Disease
- KDS2010Phase 22 trials
NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients
- BGC101autologous EnEPC preparationPhase 21 trial
Biogen · Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
- BIIB091Phase 21 trial
Biogen · Relapsing Forms of Multiple Sclerosis
- BIIB147Phase 21 trial
Biogen · Amyotrophic Lateral Sclerosis
- DiranersenISIS 814907, BIIB080Phase 21 trial
Biogen · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.